Efficacy of continuous preperitoneal infusion of ropivacaine in laparoscopic colorectal surgery

Phase 4

Completed

• Conditions: This study investigates postoperative analgesic efficacy and recovery in patients receiving continuous preperitoneal ropivacaine infusion vs. intravenous patient controlled analgesia after laparoscopic colorectal surgery.; Anaesthesiology - Pain management; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12611000183987
• Lead Sponsor: Samsung Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-02-16
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

ASA PS 2-3 patients undertaking laparoscopic colorectal surgery

Exclusion Criteria

patients with previous opioid analgesic medication
allergic to local anesthetics or opioid
coagulopathy or hemostatic abnormalities
neurologic disorder / mental disorder
obesity BMI > 30

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Decrease in Visual analogue scale (VAS)[postoperative 2hr, 6hr, 24hr, 48hr, 72hr]

Secondary Outcome Measures

Name	Time	Method
return of bowel movement (flatus)[exact time checking during postoeprative period];reduced consumption of rescue analgesics[postoeprative 2hr, 6hr, 24hr, 48hr, 72hr]